MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Yoshihiro Nakagawa
Yoshihiro NakagawaTAKEDA PHARMACEUTICAL COMPANY LIMITED

Yoshihiro Nakagawa

General Counsel at TAKEDA PHARMACEUTICAL COMPANY LIMITED

Manager

Deal Bio

Total Deals6
Valued Deals6
Total Value£ 8.89 B
Avg. Deal Size£ 1.48 B

Market Context

Sort

08 May 2019|Japan|Pharmaceuticals
XIIDRA
Novartis

Target: XIIDRA

Bidder: NOVARTIS AG

8 Service Providers

2 Bidder | 6 Vendor

52 Dealmakers

29 Bidder | 23 Vendor

£ 4.07 B

Value

26 Feb 2020|United States|Pharmaceuticals
Pvp Biologics
Takeda Pharmaceutical Company

Target: PVP BIOLOGICS INC

Bidder: TAKEDA PHARMACEUTICAL COMPANY LIMITED

4 Service Providers

2 Target | 2 Bidder

12 Dealmakers

4 Target | 8 Bidder

£ 255 M

Value

24 Aug 2020|Japan|Health Care Services
Takeda Consumer Healthcare Company
Blackstone Group

Target: TAKEDA CONSUMER HEALTHCARE COMPANY

Bidder: BLACKSTONE GROUP INC

10 Service Providers

1 Target | 5 Bidder | 4 Vendor

38 Dealmakers

1 Target | 15 Bidder | 22 Vendor

£ 1.76 B

Value

16 Sep 2020|Japan|Medical Equipment
Takeda (tachosil)
Gtcr

Target: TAKEDA (TACHOSIL)

Bidder: GTCR LLC

9 Service Providers

5 Bidder | 4 Vendor

78 Dealmakers

12 Bidder | 66 Vendor

£ 320 M

Value

05 Nov 2020|United States|Biotechnology
Velosbio
Merck & Co

Target: VELOSBIO INC

Bidder: MERCK & CO

17 Service Providers

4 Target | 4 Bidder | 9 Vendor

55 Dealmakers

20 Target | 9 Bidder | 26 Vendor

£ 2.12 B

Value

09 Mar 2021|United States|Pharmaceuticals
Maverick Therapeutics
Takeda Pharmaceutical Company

Target: MAVERICK THERAPEUTICS

Bidder: TAKEDA PHARMACEUTICAL COMPANY LIMITED

3 Service Providers

2 Target | 1 Bidder

12 Dealmakers

5 Target | 7 Bidder

£ 379 M

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite